Pepgen inc. investigated by shareholder rights advocates - investors should contact levi & korsinsky regarding potential securities law violations - pepg

New york, ny / accesswire / august 12, 2024 / levi & korsinsky notifies investors that it has commenced an investigation of pepgen inc. ("pepgen") (nasdaq:pepg) concerning possible violations of federal securities laws. on july 30, 2024, pepgen released data from its ongoing phase 2 trial of its drug candidate pgn-edo51.
PEPG Ratings Summary
PEPG Quant Ranking